BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Staging
914 results:

  • 1. SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Vázquez-Vicente D; Boria F; Castellanos T; Gutierrez M; Chacon E; Manzour N; Minguez JA; Martin-Calvo N; Alcazar JL; Chiva L;
    Int J Gynecol Cancer; 2024 Feb; 34(2):203-208. PubMed ID: 38669163
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
    Albano C; Biolatti M; Mazibrada J; Pasquero S; Gugliesi F; Lo Cigno I; Calati F; Bajetto G; Riva G; Griffante G; Landolfo S; Gariglio M; De Andrea M; Dell'Oste V
    Front Cell Infect Microbiol; 2024; 14():1359367. PubMed ID: 38529474
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
    Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
    Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Repairing partial suprahyoid epiglottis-preserved circumferential defect in near total laryngectomy with anterior medial thigh flap in advanced laryngeal cancer].
    Yang L; Li W; Zheng Y; Ji L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Feb; 38(2):133-139. PubMed ID: 38385223
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
    Khessib T; Jha P; Davidzon GA; Iagaru A; Shah J
    Semin Nucl Med; 2024 Mar; 54(2):270-292. PubMed ID: 38342655
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
    Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
    Ma GF; Lin GL; Wang ST; Huang YY; Xiao CL; Sun J; Shi TY; Xiang LB
    BMC Womens Health; 2024 Jan; 24(1):81. PubMed ID: 38297248
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Radiologic extranodal extension for nodal staging in nasopharyngeal carcinoma.
    Ai QYH; King AD; Yuan H; Vardhanabhuti V; Mo FKF; Hung KF; Hui EP; Kwong DL; Lee VH; Ma BBY
    Radiother Oncol; 2024 Feb; 191():110050. PubMed ID: 38101457
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
    Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
    Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
    Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
    J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of the diagnostic value of [
    Lyu Y; Chen X; Liu H; Xi Y; Feng W; Li B
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1163-1172. PubMed ID: 38032383
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
    Maeda M; Mabuchi S; Sakata M; Deguchi S; Kakubari R; Matsuzaki S; Hisa T; Kamiura S
    Jpn J Clin Oncol; 2024 Feb; 54(2):146-152. PubMed ID: 37935434
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The diagnostic yield of preoperative screening for oral cancer in dogs over 15 years, part 1: locoregional screening.
    Goldschmidt S; Soltero-Rivera M; Quiroz A; Wong K; Rebhun R; Zwingenberger A; Ren Y; Taylor S; Arzi B
    J Am Vet Med Assoc; 2023 Dec; 261(S2):S14-S23. PubMed ID: 37863103
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid cancer.
    Roh YH; Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
    Korean J Radiol; 2023 Oct; 24(10):1028-1037. PubMed ID: 37793671
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.
    Aissaoui O; Phalippou J; Cordoba A; Azais H; Ouldamer L; Bolze PA; Ballester M; Huchon C; Mimoun C; Akladios C; Lecointre L; Raimond E; Graesslin O; Carcopino X; Lavoué V; Bendifallah S; Touboul C; Dabi Y; Canlorbe G; Koskas M; Chauvet P; Collinet P; Kerbage Y
    Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():128-134. PubMed ID: 37788511
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lymph node size detected by magnetic resonance imaging for prediction of lymph node involvement in locally advanced cervical cancer.
    Avcı F; Kulhan M; Guler AH; Ates MC; Celik C; Bilgi A; Kulhan NG
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8889-8894. PubMed ID: 37782197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Optimal Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes to Predict Outcomes in Nasopharyngeal Carcinoma: A Two-Center Study.
    Zhu Y; Luo C; Zhou S; Li H; Liu L; Kou KI; Lei F; Zhang G; Cao D; Liang Z
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329984. PubMed ID: 37753859
    [No Abstract]    [Full Text] [Related]  

  • 20. The prognostic value of FIGO staging defined by combining MRI and [
    Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
    Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 46.